Form 4: Juniper Capital II Reports PEDEVCO Director Stock Grant
Insider Transaction Report
Juniper Capital II GP, L.P. reported the indirect acquisition of 49,396 shares of PEDEVCO CORP common stock, issued as restricted stock to director Joshua Schmidt for services.
Summary
- Juniper Capital II GP, L.P., a 10% owner of PEDEVCO CORP (PED), reported the indirect acquisition of 49,396 shares of Common Stock.
- The shares were issued as Restricted Common Stock to Joshua Schmidt, a designated director of an affiliate of the Reporting Person, on November 13, 2025.
- The issuance was pursuant to the Issuer's 2021 Equity Incentive Plan and serves as consideration for services rendered and agreed to be rendered as a member of the Board of Directors.
- The shares are subject to forfeiture and vest at a rate of 25% on the three, six, nine, and twelve-month anniversaries of October 31, 2025, contingent on Mr. Schmidt's continued service.
- The shares were transferred to Juniper Capital II PED Holdings, LLC and NPR Partners PED Holdings, LLC, entities wholly owned and controlled by investment funds for which Juniper Capital II GP, L.P. is the sole general partner.
Sentiment
Score: 7
Explanation: This filing reports a routine director compensation event through restricted stock, which is generally positive for aligning interests but does not represent a significant operational or financial catalyst for the company.
Positives
- The grant of restricted stock to a director aligns the director's interests with those of shareholders, encouraging long-term commitment and performance.
- The vesting schedule incentivizes the director's continued service to the Issuer over a twelve-month period.
Negatives
- The issuance of new shares, even restricted, can lead to minor dilution for existing shareholders.
- There is no direct cash inflow to the company from this specific equity grant.
Risks
- The restricted shares are subject to forfeiture if the director's service to the Issuer ceases before the vesting dates.
Future Outlook
The vesting schedule for the restricted shares indicates a future commitment from the director, Joshua Schmidt, to continue service to PEDEVCO CORP for at least the next twelve months from October 31, 2025, to fully realize the equity compensation.
Industry Context
The issuance of restricted stock to directors is a common practice in publicly traded companies across various industries. It serves as a non-cash compensation method designed to align the interests of the board members with the long-term performance and shareholder value of the company.
Comparison to Industry Standards
- Granting equity, particularly restricted stock, to non-executive directors is a standard compensation practice, often seen in companies like ExxonMobil, Chevron, or smaller independent energy producers, to incentivize long-term commitment and performance.
- The vesting schedule over a year is typical for such grants, ensuring retention and alignment over a reasonable period, similar to equity grants observed in technology firms like Microsoft or Apple for their board members.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Utilization | The issuance of restricted stock was made pursuant to the Issuer's 2021 Equity Incentive Plan, demonstrating the company's established framework for equity-based compensation. | 11/13/2025 | Reinforces the company's commitment to using equity to incentivize and retain key personnel, including directors, aligning their interests with long-term shareholder value. |
Related Party Transactions
- Joshua Schmidt, a director of PEDEVCO CORP, received restricted stock. Juniper Capital II GP, L.P., a 10% owner and an affiliate of Mr. Schmidt, indirectly acquired beneficial ownership of these shares through entities it controls (Juniper Capital II PED Holdings, LLC and NPR Partners PED Holdings, LLC).
Stakeholder Impact
- Shareholders: Potential minor dilution from the issuance of new shares, but also benefit from enhanced alignment of director interests with long-term company performance.
- Director (Joshua Schmidt): Receives equity compensation for services, subject to a vesting schedule that incentivizes continued service.
- Juniper Capital II GP, L.P.: Increases its indirect beneficial ownership in PEDEVCO CORP, further solidifying its stake and influence.
Next Steps
- Vesting of 25% of the restricted shares on the three-month anniversary of October 31, 2025.
- Vesting of 25% of the restricted shares on the six-month anniversary of October 31, 2025.
- Vesting of 25% of the restricted shares on the nine-month anniversary of October 31, 2025.
- Vesting of 25% of the restricted shares on the twelve-month anniversary of October 31, 2025.
Key Dates
| Date | Description |
|---|---|
| 10/31/2025 | Base date for the commencement of the vesting schedule for the restricted shares. |
| 11/13/2025 | Transaction date for the acquisition of 49,396 shares of Common Stock. |
| 11/17/2025 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed. |
Recommendation
holdThis Form 4 details a routine grant of restricted stock to a director as compensation for services, a common practice to align management and shareholder interests. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation based solely on this filing. Therefore, a 'hold' recommendation is appropriate as this is a neutral event.
Keywords
PEDEVCO, PED, Form 4, Insider Transaction, Restricted Stock, Equity Incentive Plan, Director Compensation, Beneficial Ownership, Juniper Capital
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.